Applying implementation frameworks to the clinical trial context

被引:17
作者
Stensland, Kristian D. [1 ,2 ]
Sales, Anne E. [2 ,3 ,4 ,5 ]
Damschroder, Laura J. [3 ]
Skolarus, Ted A. [1 ,3 ]
机构
[1] Univ Michigan, Dept Urol, Dow Div Hlth Serv Res, NCRC Bldg 16,100S-12 2800 Plymouth Rd, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Learning Hlth Sci, Ann Arbor, MI 48109 USA
[3] VA Ann Arbor Healthcare Syst, Ctr Clin Management Res, Ann Arbor, MI USA
[4] Univ Missouri, Sinclair Sch Nursing, Columbia, MO USA
[5] Univ Missouri, Sch Med, Dept Family & Community Med, Columbia, MO USA
来源
IMPLEMENTATION SCIENCE COMMUNICATIONS | 2022年 / 3卷 / 01期
关键词
Implementation outcomes; Determinants; Implementation research logic model; Consolidated framework for implementation research; Implementation mapping; Clinical trials;
D O I
10.1186/s43058-022-00355-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundClinical trials advance science, benefit society, and provide optimal care to individuals with some conditions, such as cancer. However, clinical trials often fail to reach their endpoints, and low participant enrollment remains a critical problem with trial conduct. In these ways, clinical trials can be considered beneficial evidence-based practices suffering from poor implementation. Prior approaches to improving trials have had difficulties with reproducibility and limited impact, perhaps due to the lack of an underlying trial improvement framework. For these reasons, we propose adapting implementation science frameworks to the clinical trial context to improve the implementation of clinical trials.Main textWe adapted an outcomes framework (Proctor's Implementation Outcomes Framework) and a determinants framework (the Consolidated Framework for Implementation Research) to the trial context. We linked these frameworks to ERIC-based improvement strategies and present an inferential process model for identifying and selecting trial improvement strategies based on the Implementation Research Logic Model. We describe example applications of the framework components to the trial context and present a worked example of our model applied to a trial with poor enrollment. We then consider the implications of this approach on improving existing trials, the design of future trials, and assessing trial improvement interventions. Additionally, we consider the use of implementation science in the clinical trial context, and how clinical trials can be "test cases" for implementation research.ConclusionsClinical trials can be considered beneficial evidence-based interventions suffering from poor implementation. Adapting implementation science approaches to the clinical trial context can provide frameworks for contextual assessment, outcome measurement, targeted interventions, and a shared vocabulary for clinical trial improvement. Additionally, exploring implementation frameworks in the trial context can advance the science of implementation through both "test cases" and providing fertile ground for implementation intervention design and testing.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Implementation capital: merging frameworks of implementation outcomes and social capital to support the use of evidence-based practices
    Jennifer Watling Neal
    Zachary P. Neal
    Implementation Science, 14
  • [32] Implementation capital: merging frameworks of implementation outcomes and social capital to support the use of evidence-based practices
    Neal, Jennifer Watling
    Neal, Zachary P.
    IMPLEMENTATION SCIENCE, 2019, 14 (1)
  • [33] Implementation of Proteomics in Clinical Trials
    He, Tianlin
    PROTEOMICS CLINICAL APPLICATIONS, 2019, 13 (02)
  • [34] Implementation of a pharmaceutical care programme for patients receiving new molecular-targeted agents in a clinical trial unit
    Riu, G.
    Gaba, L.
    Victoria, I.
    Molas, G.
    do Pazo, F.
    Gomez, B.
    Creus, N.
    Vidal, L.
    EUROPEAN JOURNAL OF CANCER CARE, 2018, 27 (01)
  • [35] Implementation research in clinical trials
    Wensing, Michel
    JOURNAL OF EVIDENCE BASED MEDICINE, 2021, 14 (02) : 85 - 86
  • [36] A framework for applying unfamiliar trial designs in studies of rare diseases
    Gupta, Samir
    Faughnan, Marie E.
    Tomlinson, George A.
    Bayoumi, Ahmed M.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (10) : 1085 - 1094
  • [37] Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges
    Kennedy, Stephen B.
    Neaton, James D.
    Lane, H. Clifford
    Kieh, Mark W. S.
    Massaquoi, Moses B. F.
    Touchette, Nancy A.
    Nason, Martha C.
    Follmann, Dean A.
    Boley, Fatorma K.
    Johnson, Melvin P.
    Larson, Gregg
    Kateh, Francis N.
    Nyenswah, Tolbert G.
    CLINICAL TRIALS, 2016, 13 (01) : 49 - 56
  • [38] Implementation of a 24/7 Enrollment Process Improves Recruitment Rate in a Multi-Center, Randomized Clinical Trial
    Shen, Loren F.
    Jacobs, Amber N.
    Rahbar, Mohammad H.
    Ford, Gary A.
    Macdonald, Claire
    Piechowski, Bart
    Roffe, Christine
    Alexandrov, Andrei V.
    Levine, Steven R.
    Sangha, Navdeep S.
    Ajani, Zahra G.
    Mullen, Michael
    Pandurengan, Renganayaki
    Grotta, James C.
    Barreto, Andrew D.
    STROKE, 2015, 46
  • [39] Facilitating future implementation and translation to clinical practice: The Implementation Planning Assessment Tool for clinical trials
    Kowalski, Christine P.
    Kawentel, Linda M.
    Kyriakides, Tassos C.
    Davis, Lori
    Bowersox, Nicholas W.
    Kilbourne, Amy M.
    Huang, Grant D.
    Nevedal, Andrea L.
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 6 (01)
  • [40] Designing an implementation strategy to increase health-related social needs screening: Applying the PRISM framework in a resource-limited clinical setting
    Byhoff, Elena
    Leclair, Amy M.
    Smith, Cara N.
    Roy, Tuhin K.
    Drainoni, Mari-Lynn
    TRANSLATIONAL BEHAVIORAL MEDICINE, 2024, 14 (03) : 197 - 205